Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
52.5%
% of XPH's 40 holdings also in PJP
70.0%
% of PJP's 30 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.3% | 5.3% | 4.3% |
|
JOHNSON & JOHNSON | 4.1% | 5.3% | 4.1% |
|
TARSUS PHARMACEUTICALS, INC. | 4.2% | 3.7% | 3.7% |
|
PFIZER INC | 3.7% | 4.7% | 3.7% |
|
MERCK & CO. INC. | 3.6% | 4.8% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PJP
|
ROYALTY PHARMA PLC CLASS A | 4.2% |
|
ZOETIS INC | 3.9% |
|
AXSOME THERAPEUTICS, INC. | 3.7% |
|
ELANCO ANIMAL HEALTH, INC. | 3.5% |
|
ORGANON & CO. | 3.2% |
|
ARVINAS, INC. | 2.8% |
|
EDGEWISE THERAPEUTICS, INC. | 2.1% |
|
HARROW INC | 1.9% |
|
CORCEPT THERAPEUTICS INC | 1.7% |
|
VIATRIS, INC. | 1.5% |
XPH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.4% |
|
GILEAD SCIENCES INC | -5.3% |
|
AMGEN INC | -5.0% |
|
ABBVIE INC | -4.8% |
|
BIOGEN IDEC INC | -2.5% |
|
UNITED THERAPEUTICS CORP | -2.4% |
|
REGENERON PHARMACEUTICALS | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.2% |
|
GERON CORP | -1.6% |
|
BIOSANTE PHARMACEUTICALS INC | -1.6% |